Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease

Clinical trial NCT00477802 · TERMINATED

Trial details

NCT number: NCT00477802
Sponsor: University of Cincinnati
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2007-05-01
Primary completion: 2008-11-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.